Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
convenience the core debate Foundayo enters the market just four months after Novo Nordisk launched oral Wegovy, highlighting contrasting competitive positions: Eli Lillys advantage: No fasting requirement, improving real-world adherence Novo Nordisks position: Clinical data shows ~14% weight loss, compared to 1011% for Foundayo No head-to-head trials have been conducted Pricing and access strategy To expand access amid high demand and limited insurance coverage: Cash-pay patients: ~$149/month (starter dose) Insured patients: Eli Lilly offers pricing as low as $25/month Commercial outlook Analysts expect Foundayo to become one of the most successful drugs in history: 2026 U.S
They offer nutrition advice personalized to match your treatment plan
Baxter, S
Do not rub the injection site, as this can disperse the medication and cause discomfort
US$ 21.16
US$ 28.93
US$ 29.68
US$ 27.85
US$ 25.79
US$ 20.29
